BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28465353)

  • 21. The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.
    Albor A; El-Hizawi S; Horn EJ; Laederich M; Frosk P; Wrogemann K; Kulesz-Martin M
    J Biol Chem; 2006 Sep; 281(35):25850-66. PubMed ID: 16816390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis.
    Liu J; Zhang C; Wang XL; Ly P; Belyi V; Xu-Monette ZY; Young KH; Hu W; Feng Z
    Cell Death Differ; 2014 Nov; 21(11):1792-804. PubMed ID: 25146927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.
    Otaki Y; Takahashi H; Watanabe T; Funayama A; Netsu S; Honda Y; Narumi T; Kadowaki S; Hasegawa H; Honda S; Arimoto T; Shishido T; Miyamoto T; Kamata H; Nakajima O; Kubota I
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.
    Hu Z; Song Q; Ma H; Guo Y; Zhang T; Xie H; Luo X
    J Bioenerg Biomembr; 2021 Jun; 53(3):309-320. PubMed ID: 33694017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
    Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
    Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of Trim32 Enhances Motor Function Repair after Traumatic Brain Injury Associated with Antiapoptosis.
    Zhang ZB; Xiong LL; Lu BT; Zhang HX; Zhang P; Wang TH
    Cell Transplant; 2017 Jul; 26(7):1276-1285. PubMed ID: 28933219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.
    Xiong Y; Bedi K; Berritt S; Attipoe BK; Brooks TG; Wang K; Margulies KB; Field J
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30762586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level.
    Romá-Mateo C; Moreno D; Vernia S; Rubio T; Bridges TM; Gentry MS; Sanz P
    BMC Evol Biol; 2011 Jul; 11():225. PubMed ID: 21798009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
    Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
    Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysbindin deficiency Alters Cardiac BLOC-1 Complex and Myozap Levels in Mice.
    Borlepawar A; Schmiedel N; Eden M; Christen L; Rosskopf A; Frank D; Lüllmann-Rauch R; Frey N; Rangrez AY
    Cells; 2020 Oct; 9(11):. PubMed ID: 33142804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation.
    Ichimura T; Taoka M; Shoji I; Kato H; Sato T; Hatakeyama S; Isobe T; Hachiya N
    J Cell Sci; 2013 May; 126(Pt 9):2014-26. PubMed ID: 23444366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E3-ubiquitin ligase TRIM6 aggravates myocardial ischemia/reperfusion injury via promoting STAT1-dependent cardiomyocyte apoptosis.
    Zeng G; Lian C; Yang P; Zheng M; Ren H; Wang H
    Aging (Albany NY); 2019 Jun; 11(11):3536-3550. PubMed ID: 31171760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRIM32-Cytoplasmic-Body Formation Is an ATP-Consuming Process Stimulated by HSP70 in Cells.
    Kawaguchi Y; Taoka M; Takekiyo T; Uekita T; Shoji I; Hachiya N; Ichimura T
    PLoS One; 2017; 12(1):e0169436. PubMed ID: 28052117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host's NF-κB Signalling Activity.
    Yang Z; Soderholm A; Lung TW; Giogha C; Hill MM; Brown NF; Hartland E; Teasdale RD
    PLoS One; 2015; 10(9):e0138529. PubMed ID: 26394407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIM32 regulates mitochondrial mediated ROS levels and sensitizes the oxidative stress induced cell death.
    Prajapati P; Gohel D; Shinde A; Roy M; Singh K; Singh R
    Cell Signal; 2020 Dec; 76():109777. PubMed ID: 32918979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.
    Sato T; Okumura F; Kano S; Kondo T; Ariga T; Hatakeyama S
    J Cell Sci; 2011 Oct; 124(Pt 20):3492-502. PubMed ID: 21984809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.
    Song DW; Ryu JY; Kim JO; Kwon EJ; Kim DH
    Biochem J; 2014 Jan; 457(1):151-62. PubMed ID: 24117217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer.
    Ma Y; Zhang H; Chen C; Liu L; Ding T; Wang Y; Ma D; Ling X; Chen X; Li J; Guansheng ; Zhong ; Ru G; Zhang L; Tang J
    Oncogene; 2022 Mar; 41(11):1589-1599. PubMed ID: 35091679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDK2-activated TRIM32 phosphorylation and nuclear translocation promotes radioresistance in triple-negative breast cancer.
    Tang J; Li J; Lian J; Huang Y; Zhang Y; Lu Y; Zhong G; Wang Y; Zhang Z; Bai X; Fang M; Wu L; Shen H; Wu J; Wang Y; Zhang L; Zhang H
    J Adv Res; 2024 Jul; 61():239-251. PubMed ID: 37734566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.